Skip to main content

뉴스

Positive topline results announced for TRAILBLAZER 3

으로 회전식 슬라이더, 뉴스에서, UCI 마음
May 3, 2023–Eli Lilly and company announced today (https://investor.lilly.com/news-releases/news-release-details/lillys-donanemab-significantly-slowed-cognitive-and-functional) the positive topline results from their Phase 3 clinical trial of donanemab, a monoclonal antibody that rapidly lowers beta amyloid levels…
더 읽어보기
한국어